IGHD613: Key Regulator of Immune Response and Myelination (G28487)

Target Name: IGHD6-13

NCBI ID: G28487

IGHD6-13

Other Name(s): IGHD613 | DN1 | immunoglobulin heavy diversity 6-13 | Immunoglobulin heavy diversity 6-13

IGHD613: Key Regulator of Immune Response and Myelination

IGHD6-13 (IGHD613) is a protein that is expressed in the immune cells of the body. It is a key regulator of the immune response and has been identified as a potential drug target in the field of immunology.

IGHD613 is a member of the intergenital development (IGD) family, which includes a number of transcription factors that play a role in the development and regulation of tissues and organs. IGHD613 is specifically expressed in the hematopoietic stem cells (HSCs) and is involved in the development and proliferation of these cells.

IGHD613 has been shown to play a role in the regulation of the immune response. It has been shown to be involved in the development of T cells, which are a critical component of the immune system. IGHD613 has been shown to promote the development and proliferation of T cells, and it has been shown to play a role in the regulation of the T cell receptor (TCR), which is a key molecule that allows T cells to recognize and respond to foreign substances in the body.

IGHD613 has also been shown to play a role in the regulation of the myelination process. Myelination is the process by which the myelin sheath that surrounds the neural axons is produced and it is an important part of the immune response. IGHD613 has been shown to be involved in the regulation of myelination, and it has been shown to play a role in the development and maintenance of the myelination.

In addition to its role in the immune system, IGHD613 has also been shown to play a role in the regulation of cell signaling processes. It has been shown to be involved in the regulation of the Notch signaling pathway, which is a key pathway that involves the interaction between cells and the regulation of gene expression.

IGHD613 has also been shown to play a role in the regulation of the cell cycle. It has been shown to be involved in the regulation of the G1 phase of the cell cycle, which is the phase of the cell cycle where the cell prepares for cell division.

In conclusion, IGHD613 is a protein that has been shown to play a number of important roles in the immune system and in cell signaling processes. As a result, it has potential as a drug target for a variety of diseases. Further research is needed to fully understand the role of IGHD613 in the immune system and to develop effective treatments based on this protein.

Protein Name: Immunoglobulin Heavy Diversity 6-13

The "IGHD6-13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHD6-13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets